Daily pill cuts breast cancer risk in half
Under the current system, when drugs lose their patent and become generic, meaning they can be sold by any manufacturer, pharmaceutical companies have little incentive to file new license applications. As a result, drugs that have shown promise for purposes other than those for which they were authorized, such as prevention rather than treatment, end …